HybPAT HybPAT fosters the implementation of the Process Analytic Technology (PAT) initiative by providing hybrid modeling solutions for pharma.

Hybrid modeling has proven advantages over current best industrial practice, which can be directly translated into a reduction of process development time by 20-50%. Our team consists of leading experts on hybrid modeling and its application for process modeling, monitoring, optimization and control. We successfully accomplished several projects with pharma for fast process development based on hybrid models.

HybPAT Dr Moritz von Stosch review on AICHE ! Hybrid Modeling: A Smart Way to Use All Available Knowledge
02/10/2014

HybPAT Dr Moritz von Stosch review on AICHE ! Hybrid Modeling: A Smart Way to Use All Available Knowledge

Imagine you want to make beer, and not just any beer, but great beer. Learn more about how this and other processes can be optimized using hybrid modeling.

Dr. Moritz von Stosch - euPAT6
10/03/2013

Dr. Moritz von Stosch - euPAT6

Register Now !
05/17/2013

Register Now !

Hybrid models exhibit a number of advantages over other prevailing modeling concepts. The main advantage is a higher benefit/cost ratio to solve complex problems, which is a key factor for applied research. Yet hybrid models are rarely applied in both academia and industry. Hybrid models incorporate...

Moritz von Stosch - HybPAT coFounder
05/07/2013

Moritz von Stosch - HybPAT coFounder

Visit us!
04/09/2013

Visit us!

Visualize o perfil profissional de Cristiana de Azevedo (Portugal) no LinkedIn. O LinkedIn é a maior rede de negócios do mundo, que ajuda profissionais como Cristiana de Azevedo a descobrir conexões internas para candidatos recomendados para o cargo, especialistas do setor e parceiros de negócios.

Address

Cambridge, MA
02138

Website

Alerts

Be the first to know and let us send you an email when HybPAT posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share